Compare BAX & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAX | TPG |
|---|---|---|
| Founded | 1931 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 8.9B |
| IPO Year | N/A | 2022 |
| Metric | BAX | TPG |
|---|---|---|
| Price | $20.40 | $65.90 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $25.67 | ★ $66.45 |
| AVG Volume (30 Days) | ★ 7.9M | 1.4M |
| Earning Date | 02-12-2026 | 02-10-2026 |
| Dividend Yield | 0.19% | ★ 2.50% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | ★ $11,023,000,000.00 | $4,255,344,000.00 |
| Revenue This Year | $5.20 | N/A |
| Revenue Next Year | $2.00 | $31.12 |
| P/E Ratio | ★ N/A | $714.65 |
| Revenue Growth | 3.90 | ★ 24.91 |
| 52 Week Low | $17.40 | $37.52 |
| 52 Week High | $37.74 | $70.38 |
| Indicator | BAX | TPG |
|---|---|---|
| Relative Strength Index (RSI) | 64.47 | 56.47 |
| Support Level | $19.04 | $63.79 |
| Resistance Level | $19.49 | $70.38 |
| Average True Range (ATR) | 0.42 | 1.68 |
| MACD | 0.18 | -0.06 |
| Stochastic Oscillator | 80.34 | 36.87 |
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company focuses on large-scale, control-oriented private equity investments.